Chronic Kidney Disease Trial, Recruiting NCT06693661 Sponsor: Emory University Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06693661
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as African American or Black
  • People who have had two kidney function test results (called eGFR) below 29, taken at least 90 days apart but within the past 2 years — OR — people whose kidney failure risk score shows a 10% or greater chance of kidney failure within the next 2 years
  • People who have had at least one visit at Emory Healthcare — either an outpatient appointment, an emergency room visit, or a hospital stay — within the past 2 months
  • People who are willing to follow all study requirements and are available for the full duration of the study

Who may not be able to join:

  • People who are currently on dialysis
  • People who are currently receiving hospice care or other end-of-life care for a terminal illness
  • People who are currently on a transplant waiting list, have been referred for a transplant evaluation, or have completed a transplant evaluation visit within the past 2 years
  • People who have previously received a kidney transplant or any other solid organ transplant
  • People who are currently undergoing treatment for cancer
  • People whose primary language is not English
  • People who are already taking part in another treatment or intervention study at the time of enrollment
  • People who are currently pregnant or planning to become pregnant at the time of recruitment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kimberly R Jacob Arriola, PhD, MPH, Emory University

Phone: 404-727-2600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 March 2026
Est. completion
1 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time-to-Kidney Replacement Therapy w/Central Venous Catheter; Time-to-death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov